WASHINGTON--(BUSINESS WIRE)--The following statement was issued today by Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood in conjunction with a hearing being held this morning on follow-on biologics before the House Oversight and Government Reform Committee:
